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For personalObjective: A cohort study was carried out to determine the incidence of MRSA acquisition and
its risk factors in AD children.
Methods: Patients with AD (2 monthse14 years old) were followed up for about 1 year at a
reference center for AD treatment in Rio de Janeiro, Brazil, from September 2011 to February
2014. Nasal swabs from patients and contacts were collected every 2 months. The SCORAD sys-
tem assessed the severity of the AD. S. aureus isolates were evaluated to determine the meth-
icillin resistance and the clonal lineages.
Results: Among 117 AD patients, 97 (82.9%) were already colonized with S. aureus and 26
(22.2%) had MRSA at the first evaluation. The incidence of MRSA acquisition in the cohort study
was 27.47% (n Z 25). The SCORAD assessments were: mild (46.15%), moderate (37.36%) or se-
vere (16.48%). Risk factors were: colonized MRSA contacts (HR Z 2.27; 95% CI: 1.16e7.54), use
of cyclosporine (HR Z 5.84; 95% CI: 1.70e19.98), moderate or severe AD (HR Z 3.26; 95% CI:
1.13e9.37). Protective factors were: availability of running water (HR Z 0.21; 95% CI: 0.049
e0.96) and use of antihistamines (HR Z 0.21; 95% IC: 0.64e0.75). MRSA isolates carried the
SCCmec type IV and most of them were typed as USA800/ST5.
Conclusions: The high incidence of MRSA acquisition found among AD patients and the risk fac-
tors associated show that an effective surveillance of MRSA colonization in these patients is
needed.
Copyright ª 2019, Taiwan Society of Microbiology. Published by Elsevier Taiwan LLC. This is an
open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-
nc-nd/4.0/).Introduction
Atopic dermatitis (AD) is a chronic inflammatory disease
and one important symptom is the itching that helps spread
this skin inflammation. Although present in all age groups,
children under five years old are the most affected; the
incidence of AD decreases progressively in adulthood.1 AD is
distributed worldwide, although there is a higher preva-
lence in urban centers. In Brazil, the prevalence of AD is
around 6e8% in 6 to 13-year-olds, however among younger
individuals this rate is unknown.2
In the literature there are several scoring systems for
evaluating and monitoring AD: “Severity Scoring Index of
Atopic Dermatitis” (SCORAD), “Eczema Area and Severity
Index” (EASI), and “Six Area Six Sign Atopic Dermatitis
Atopic Score” (SASSAD), among others.3,4 In addition, the
disease can vary from mild to severe, and requires effective
therapeutic strategies and support.5,6
The etiology of AD has not yet been fully clarified and
the current literature describes many factors, including
those in the genetic and environmental fields.7 Staphylo-
coccus aureus is an important risk factor for worsening of
AD.8
Methicillin-resistant S. aureus (MRSA) isolates have also
been detected in patients with AD and usually carry a
staphylococcal chromosome cassette mec (SCCmec) of
community origin, such as types IV or V. Moreover, many
studies indicate that the genetic profile of most MRSA iso-
lates recovered from these patients belongs to well-
established community lineages.9,10
Several studies evaluated the prevalence of S. aureus
and MRSA colonization in AD patients. Suh et al. observed
that S. aureus colonization occurred in 80% of AD cases in
USA and 16% were MRSA.11 In New Zealand, 75% of AD pe-
diatric patients were colonized but only 2% with MRSA.12 In
Singapore13 and in Porto Alegre, Brazil,14 the authors alsoymous User (n/a) at University of Groning
 use only. No other uses without permissionobserved a high prevalence of S. aureus nasal colonization
in AD patients, however, MRSA isolates were not found.
Also, studies evaluating the incidence of acquiring this
pathogen colonization have not been conducted. This study
aimed to evaluate the incidence of nasal MRSA acquisition
and identify possible risk factors associated with pediatric
patients who were being followed-up at an outpatient
clinic, through a cohort, of a public university hospital in
Rio de Janeiro. In addition, the genotyping of the MRSA
isolates recovered from the patients was performed.Methods
Setting and study design
This prospective cohort study was conducted at the
Dermatology and Allergy clinic of a Public University Hos-
pital in Rio de Janeiro Brazil, from September 2011 to
February 2014. The study was approved by the Research
Ethics Committee under No. 51/11. The age of the patients
ranged from two months to 14 years old and all had been
diagnosed with AD15,16 and classified by SCORAD.3 Patients
were included if they and/or their guardians and contacts
signed the consent and/or assent form. They were accom-
panied for one year, with visits every 2e3 months. When a
patient missed a visit, a telephone contact was made to
reschedule the appointment. At every visit, the patient and
contacts answered a questionnaire and nasal swabs were
performed.
Exclusion criteria included: patients who had another
chronic dermatological disease which compromised the skin
barrier (eg. psoriasis and ichthyosis among others); a pre-
vious history of MRSA colonization; if MRSA was detected in
the nasal swab at the initial visit; if they had any other
chronic disease that could increase the risk of MRSAen from ClinicalKey.com by Elsevier on December 04, 2020.
. Copyright ©2020. Elsevier Inc. All rights reserved.
726 E.D. Abad et al.colonization (eg. cystic fibrosis, acquired immunodefi-
ciency); if they had a history of previous hospitalizations for
more than 3 months; dialysis; and if they used percuta-
neous catheters during the study period.
Demographic and clinical data
Data from questionnaires included: demographic informa-
tion; if the patient shared a bed with someone; family in-
come; previous use of antibiotics; if any family member is a
health care worker; intra-domiciliary contact; had a skin
infection at the time of the visit; had any pets. And medi-
cation: if the patient used moisturizers and/or a topical
cream (corticosteroids, calcineurin inhibitors) and/or oral
drugs (immune suppressants - corticosteroids > 1 mg/kg,
azathioprine, cyclosporine and antibiotics).
Microbiological characterization
Nasal specimens were cultured on mannitol salt agar
(Oxoid, United Kingdom) and characterized by tests stan-
dardized by Bannerman and Peacock.17 All isolates identi-
fied as S. aureus were subject to the cefoxitin disk diffusion
test to detect methicillin resistance.18 SCCmec typing was
carried out19 after extraction of bacterial DNA from the
MRSA isolates.20 Genotyping was performed by pulsed-field
gel electrophoresis (PFGE)21 and multilocus sequence
typing (MLST) methods.22
Statistical analysis
The data were stored in Microsoft Excel file and analyzed in
STATA (StataCorp. 2013. Stata Statistical software. Release
13. College Station TX. StataCorp). Central tendency,
dispersion and assessment of distribution were evaluated on
all continuous variables. The frequency distribution was
described for the categorical variables. In this analysis the
dependent variable was the time of the first visit that the
patient was MRSA colonized, with censoring at loss of follow
up or end of the study. KaplaneMeier and log-rank tests were
used to estimate the time of MRSA acquisition and to eval-
uate differences among the score categories, respectively.
The effect of covariates on the MRSA acquisition was studied
using the Cox proportional hazard models for bivariate and
multivariate analyses. In the multivariate analysis all inde-
pendent variables that presented a p-value <0.15 in the
bivariate analysis were used. Model selection for the multi-
variate Cox model was based on the likelihood ratio tests.
Logistical problems could make the evaluation of the
independent variable MRSA colonization impossible, as it
would be necessary to evaluate all the contacts of each
child and each child would have a different number of
contacts, and most of them were unable to bring all the
contacts to the clinic. So, we considered any contact MRSA
colonized or not, as an independent variable.
Results
A total of 117 patients with AD were recruited for the study
and 97 (82.90%) were already colonized with S. aureus atDownloaded for Anonymous User (n/a) at University of Groningen
For personal use only. No other uses without permission. Cthe first visit, where 26 (22.22% of total) patients presented
MRSA and 71 (60.68%) presented methicillin-susceptible S.
aureus (MSSA) isolates. Of the 91 patients followed up in
the cohort study (see Fig. 1), 14 (15.38%) dropped out
during the study. The average age of the group was 79.67
months/6.6 years old; SD:  4.1 (49.68); ranging from 2.1 to
177.13 months. There was a slight predominance of females
(49 patients, 53.85%). The distribution of patients accord-
ing to the AD severity score was 46.15%, 37.36% and 16.48%
for mild, moderate and severe, respectively. The incidence
of acquiring MRSA colonization at the end of this cohort was
27.47% (n Z 25 patients).
Approximately 28.57% of patients had used antibiotics in
the last three months and only 7.69% had had contact with
other risk factors such as inpatients or outpatients or rel-
atives working in health care facilities. A total of 41.76%
shared a bed for sleeping, 16.48% had pets (dog and/or
cat), and 94.51% had running water in their homes (Table
1). Regarding treatments: 89.01% of the patients used ste-
roid cream, 95.60% oral antihistamines, 98.90% moisturizers
and 24.17% oral immune suppressants.
The KaplaneMeier curve analysis showed that a longer
follow-up time of these patients increased the risk of MRSA
acquisition. When the severity of the disease (SCORAD) and
the number of new cases of acquiring MRSA colonization
was compared with the follow-up time, 50% of severe cases
acquired MRSA colonization within the first 100 days, there
is a remarkable difference on MRSA acquisition between the
SCORAD mild/moderate group and the SCORAD severe
group (p < 0.001, log-rank test), as shown in Fig. 2.
A total of 20,618 child/days were followed-up, the me-
dian of the follow-up was 210 days, ranging from 60 to 420
days. Some significant data was found in the bivariate
analysis: patients had a greater chance of acquiring MRSA
colonization when their contacts had skin infections
(HR Z 7.10; 95% CI: 1.61e31.25). Having running water in
the home proved to be a protective effect for MRSA colo-
nization (HR Z 0.22; 95% CI: 0.06e0.75) and the use of
antihistamines reduced the chances of acquiring MRSA
colonization (HR Z 0.22; 95% IC: 0.64e0.75). Also, thera-
peutic interventions and the use of antihistamines seems to
serve as a possible protective factor (HR Z 0.21; 95% CI:
0.64e0.75), maybe by decreasing the itching. No associa-
tion was found between the use of ATB and the colonization
by the pathogen (HR Z 1.60; 95% CI: 0.73e3.92), nor with
the variable of sharing the same bed (HR Z 1.18; 95% CI:
0.51e2.74).
The multivariate analysis showed that the risk factors
independently associated with the MRSA acquisition were:
patients who had contacts colonized by MRSA had an
increased chance of acquisition (HR Z 2.95; 95% CI: 1.16 to
7.54), and the higher the SCORAD the higher the chance of
acquiring colonization (HR Z 3.26; 95% CI: 1.13e9.37).
Also, taking cyclosporine was associated with MRSA acqui-
sition (HR Z 5.84; 95% CI: 1.70e19.9). On the other hand,
having treated running water in the home decreased the
chance of acquiring MRSA colonization (HR Z 0.21; 95% CI:
0.04e0.96) (Table 2).
All 24 MRSA isolates identified in the study carried the
SCCmec IV. Genotypic evaluation was randomly performed
on 10 isolates and six of them had profiles related to the
USA800/ST5 lineage. One MRSA isolate belonged to the from ClinicalKey.com by Elsevier on December 04, 2020.
opyright ©2020. Elsevier Inc. All rights reserved.
Figure 1. Flowchart of the cohort study and results of MRSA acquisition.
MRSA acquisition in DA patients 727USA1100/ST30 lineage and the other three isolates did not
have profiles compatible with any known clonality and were
included in STs 1, 45 and 800.Discussion
Methicillin-resistant S. aureus is a major Gram positive
pathogen in infectious diseases and it is important in pop-
ulations where colonization can contribute to the wors-
ening of the clinical picture of a disease, such as in AD
patients.8 To evaluate the incidence of MRSA colonization
among AD children is important to determine the risk of
acquisition of this pathogen. In this cohort study, after
having followed the children for one year a high incidence
of nasal MRSA acquisition (27.47%) was detected. In Brazil,
Petry and coworkers14 conducted a two-year clinical follow-
up in Porto Alegre to identify AD patients colonized by MRSA
isolates. However, they did not find MRSA among the iso-
lates. As far as the authors know, this is the first cohort
study that showed the incidence of MRSA acquisition in
pediatric patients with AD in Brazil.
In this study, 82.90% of patients were already colonized
with S. aureus at the first visit and there was a MRSA
colonization prevalence of 22.22% (26/117) in patients with
AD. In other places like Philadelphia, USA, Suh et al.11
found 13% of MRSA in AD patients, while in Rome, Italy,
Pascolini et al.23 identified 4.5% (4/117) of atopic children
colonized by the pathogen, well below the rates here. In
Brazil, although Petry et al.14 did not detect MRSA in the
nasal sites of AD patients they found 68.8% (64/93) of pa-
tients colonized by S. aureus isolates, lower findings than
ours (82.9%) and when compared to values found by otherDownloaded for Anonymous User (n/a) at University of Groning
For personal use only. No other uses without permissionauthors.11,13 The colonization by S. aureus in AD patients
can contribute to the worsening of the AD infection causing
recurrent episodes of skin infections. This phenomenon
could be in part due to decreased NMFs (“NMFs - natural
moisturizing factor”), reducing the skin humidity and thus
altering the skin buffering balance, making it more alka-
line. This change increases the action of serine proteases
(SE), which increase susceptibility to infection by S.
aureus.24
Moderate and severe AD are related to more skin ail-
ments, a greater area of body affected, more itching and
secondary infections.25,26 In the present study, the diag-
nosis of moderate or severe AD was associated to a high risk
of MRSA acquisition independently compared with mild AD
(HR Z 3.26; 95% CI 1.13e9.37; p Z 0.028). Also, the
KaplaneMeier curve analysis showed that 50% of the pa-
tients with severe AD acquired MRSA colonization within the
first 100 days (p < 0.001). Reports that show MRSA as a risk
factor for worsening AD have been based mainly on cross-
sectional studies.27 However, our cohort study also seems
to indicate that the disease severity could be a risk factor
for MRSA acquisition, reinforcing the relationship between
the two. Thus, continuous vigilance is recommended,
including a microbiological investigation for patients with
AD, especially in patients with moderate or severe AD,
since treatment of MRSA infections requires more effective
therapeutic strategies with adequate support.
The emergence of MRSA can be linked to the repetitive
use of antibiotic therapy, due to itching and to increased
cutaneous ailments among other factors.28 However, in this
study the use of antibiotics failed to demonstrate increased
risk for acquisition, possibly due to the small sample size,
and therefore our data does not corroborate the findings ofen from ClinicalKey.com by Elsevier on December 04, 2020.
. Copyright ©2020. Elsevier Inc. All rights reserved.
Table 2 Multivariate analysis of factors associated with
MRSA acquisition in patients with Atopic Dermatitis.
Characteristics HR IC p
Contacts colonized with MRSA 2.95 1.16e7.54 0.002
Availability of running water 0.21 0.04e0.96 0.044
Cyclosporine use 5.84 1.70e19.98 0.005
SCORAD:
Light 0.41 0.13e1.26 0.123
Moderate and Severe 3.26 1.13e9.37 0.028
HR: Hazard Ratio; CI Z confidence interval; p Z p value.
Table 1 Bivariate analysis of factors associated with MRSA
acquisition in 91 patients with Atopic Dermatitis.
Characteristics HR IC 95% p




Prior use of ATB 1.60 0.73e3.92 0.21
Contacts with wound
and pus at home
7.10 1.61e31.25 <0.001
Animals at home 0.61 0.18e2.06 0.43
Contacts that sleep in









Use of topical tacrolimus 1.9 0.87e4.49 0.10
Use of antihistamine 0.21 0.64e0.75 0.01
Use of moisturizer 0.01 0.00e1.00 0.74
Use of corticosteroids >
1 mg
2.7 1.06e6.92 0.03
Use of azathioprine 4.48 0.00e1.00 0.00




Gender 1.07 0.47e2.43 0.86
Age 1.00 0.99e1.01 0.33
Room per capita 0.41 0.16e1.04 0.06
Income per capita 0.99 0.99e1.00 0.18
Colonized with MRSA at
1st visit
0.72 0.16e3.08 0.66
Colonized at visit 2.25 0.97e5.22 0.05
HR: Hazard Ratio; CI Z confidence interval; p Z p value.
728 E.D. Abad et al.other authors. On the other hand, the use of systemic
antihistamine showed a HR Z 0.21 (95% CI 0.64e0.75;
p Z 0.01), demonstrating its protective factor, as its use
reduces scarification and consequent susceptibility to
pathogens.29Figure 2. KaplaneMeier curve: the relationship between
MRSA acquisition and SCORAD of patients with Atopic
Dermatitis.
Downloaded for Anonymous User (n/a) at University of Groningen
For personal use only. No other uses without permission. CCyclosporine is recommended for the treatment of se-
vere AD. This study revealed that its use is associated with
the MRSA acquisition independently of any of the other
factors analyzed (HR Z 5.84; CI 1.70e19.98; p Z 0.005).
However, Bunikowski et al.30 observed a reduction of
colonization by S. aureus in German children with AD using
this drug during an eight week follow-up. This study does
not mention any MRSA colonized patient and therefore we
could suggest that MRSA could have a mechanism to escape
the immune system that differs from MSSA. Also, patients in
our study could have distinct genetic characteristics that
tolerate greater colonization than those investigated by
Bunikowski et al.30
In the present study the fact that the patient had
running water available at home showed a protective ef-
fect against acquisition, also independently, reducing the
chance of this individual with AD to become colonized by
MRSA (HR Z 0.21; 95% CI 0.049e0.96; p Z 0.044). This
finding is in line with the results given by Hennessy et al.31
in Alaska, where the groups that lived in areas with less
access to drinking water had seven times higher risk
(RR Z 7.1; 95% CI Z 3.6e14,0) to have MRSA skin in-
fections. Also the risk of developing skin infections caused
by S. aureus including MRSA was higher among people who
lived in villages with little access to running water than for
those with better access to running water.31
In the literature there are no reports concerning the
relationship of contacts colonized with MRSA being a
possible acquisition risk factor for AD patients. In this study,
we observed an increased chance, independently, of
acquisition of the patient when the contacts were colonized
by MRSA (HR Z 2.27 CI: 1.16 to 7.54; p Z 0.002). In a study
carried out in India32 with 500 children that did not have AD
but had skin infections, an association was suggested where
contacts who were colonized by MRSA could be a risk factor
for these children (p 0.04 95% CI Z 1009e2099).
All MRSA isolates identified in this study carried the
SCCmec type IV. This is the most commonly found type of
mec cassette among community-acquired MRSA isolates in
Brazil.33 Similarly, Chung et al.9 also demonstrated the
predominance of SCCmec IV among MRSA isolates of pedi-
atric patients with AD in South Korea. On the other hand, Lo
et al.10 identified the SCCmec V as the prevalent cassette in
MRSA isolates from children with AD in Taiwan. Since the
SCCmec V/ST59 is the most common MRSA lineage present
in Taiwan communities, the molecular characteristics of
isolates from AD patients seem to be specific to each
geographical region. Among 10 MRSA isolates analyzed by from ClinicalKey.com by Elsevier on December 04, 2020.
opyright ©2020. Elsevier Inc. All rights reserved.
MRSA acquisition in DA patients 729PFGE and MLST in our study, six (60%) belonged to the
USA800/ST5 lineage and one (10%) to USA1100/ST30. A
recent study conducted by our group with Brazilian children
with AD showed that the USA800/ST5 and USA1100/ST30
isolates corresponded to about 60% of the S. aureus isolates
from patients.34
Faced with these multiple aspects involved in S. aureus
colonization, patients with AD should first be evaluated as to
the gravity independent of their status. The clinical evalu-
ation (SCORAD) should be carefully performed, because only
when the patient presents an infectious condition and after
an evaluation of the bacteria involved should decolonization
be considered. Decolonization should not be used as an
everyday event, but as a specific event, as there are already
reports of mupirocin resistance.35 Another option such as
sodium hypochlorite solution 0.005% has appeared as a good
alternative in these cases.36,37
The main limitation of this study is that the sample was
carried out in an outpatient setting with predominantly
mild SCORAD AD patients, which hampered a better
comparative analysis for different groups of AD severity.
Another aspect that limited the study was the small number
of individuals evaluated since there was a loss of 14 pa-
tients (15.38%) during follow up, despite efforts to prevent
them. This loss was mainly from patients who resided in the
greater Rio de Janeiro region and who have difficulties such
as access to social mobility.
In conclusion, this study showed an incidence of 27.47%
of MRSA acquisition within one year in children and ado-
lescents with AD in Brazil. The main risk factors for MRSA
acquisition identified were household contacts colonized
and/or infected with MRSA, the use of cyclosporine and the
clinical presentations of the disease (AD) as moderate and
severe. On the other hand, the use of antihistamine and the
availability of running water in the home acted as protec-
tive factors decreasing the chance of acquiring MRSA colo-
nization. All MRSA isolates identified in the study carried the
SCCmec IV and most of the isolates belonged to the USA800/
ST5 lineage. These findings call attention to the need for a
more effective approach to surveillance of MRSA coloniza-
tion in order to reduce the number of relapses of the dis-
ease and associated infections.
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